Marketresearchnews

Wednesday, 30 December 2020

Genotyping Market Overview By Trends, Industry Top Manufactures, Size, Industry Growth Analysis & Forecast Till 2023

Market Highlights

Genotyping is a procedure commonly used in healthcare and life sciences research activities. Genotyping is a genetic mapping of an organism which includes DNA sequencing and analysis of sequenced DNA. The surge in cases of genetic disorders, increasing demand for personalized medicines, and technological advancement are the factors that are propelling the growth of the market. Additionally, increasing R&D spending and aggressive strategies adopted by the top players, such as new product launches, are contributing to the growth of the market. For instance, in January 2018, Illumina, Inc. launched iSeq 100 Sequencing System in the market, the product contains sequencing by synthesis (SBS) along with the complementary metal-oxide-semiconductor (CMOS) detection technology which is easy to use and compact product.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6635

The unfavorable reimbursement policies, the dearth of technicians, and continues change in technology are likely to hinder market growth during the forecast period.

Regional Analysis

The market in the Americas is expected to dominate the global genotyping market during the forecast period owing to the rising demand for personalized medicines, growing research and development sector, increasing cases of genetic disorders, and well-established healthcare sector in the region. The European market is expected to be the second-largest due to government funding and support of the healthcare sector, rising investment into research and development by pharmaceutical companies, and increasing government initiatives for development of healthcare sector. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the forecast period owing to the increasing disposable income, supportive government policies, and rising investment by market players in the region. The market in the Middle East & Africa is likely to account for the smallest share of the global genotyping market.

Segmentation

The Global Genotyping Market has been segmented on the basis of technology, product, application, and end-user.

The technology segment has been segregated into sequencing, capillary electrophoresis, PCR, microarray, and mass spectrometry. The sequencing segment has been further divided into next-generation sequencing, pyrosequencing, and Sanger sequencing. The Capillary electrophoresis segment has been further divided into amplified fragment length polymorphism (AFLP),single-strand conformation polymorphism (SSCP), and restriction fragment length polymorphism (RFLP). The microarray segment has been classified as DNA microarrays, antibody microarrays, MMChips, and peptide microarrays.

On the basis of product, the market has been divided into reagents and kits, instruments, and services.

The market, by application, has been classified into diagnostics, drug discovery and development, agriculture, academic research, and personalized medicine.

The end-user segment has been classified into hospitals, diagnostic centers, academic institutes, and research and development centers.

Key Players

Some of the key players in the global genotyping market are F. Hoffmann-La Roche Ltd, QIAGEN, Thermo Fisher Scientific, Inc., Illumina, Inc, Fluidigm Corporation, General Electric Company, Affymetrix, Inc., Agilent Technologies, Inc., Sequenom, and Beckman Coulter, Inc.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/genotyping-market-6635

Ultrasound Probe Disinfection Market Value Chain, Factor Analysis, Region And Forecasts Till 2023

Market Highlights

The Ultrasound Probe Disinfection Market is expected to witness tremendous growth owing to the rising demand for disinfectant probes in hospitals, increasing cases of bacterial infection in healthcare center during the treatment, and increasing implementation of high-level disinfection process for critical ultrasound probes. The global ultrasound probe disinfection market was estimated USD 314.1 million in 2018 and expected to reach USD 819.1 million by 2023 at a healthy CAGR of 21.1% by 2023.

However, factors such as high cost of switching, maintenance cost for the ultrasonic instrument may hinder the market growth during the forecast period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6642

Segmentation

The Global Ultrasound Probe Disinfection Market is segmented on the basis of product, probe type, by process and end-user. The ultrasound probe disinfection market, by product, is segmented into instrument, service, and consumables. The instrument is segmented into automated probe reprocessors, UV-C disinfectors, manual reprocessors/soaking stations, and ultrasound transducer storage cabinets. The consumables are sub-segmented into formulation, type of disinfectants, and detergents. The disinfectants, by formulation, is segmented into disinfectant wipes, disinfectant liquids, and disinfectant sprays. By type, consumables are segmented into high-level disinfectants, and intermediate/low-level disinfectants and detergents are segmented into enzymatic detergents and non-enzymatic detergents.

By probe type the market is segmented into linear transducers, convex transducers, phased array transducers, endocavitary transducers, transesophageal echocardiography transducers| (TEE), and other. On the basis of process, the market is segmented into high-level disinfection and intermediate/low-level disinfection. On the basis of end-user, the market is segmented into hospitals and clinics, diagnostic centers, ambulatory care centers, academic & research institutes, and others.

Regional Analysis

The Americas leads in the market owing to the increasing prevalence of rising incidence of bacterial infection, increasing research & development in ultrasound probe disinfection and growing healthcare expenditure. According to the Consumer Report Organization and Centers for Disease Control and Prevention (CDC) July 2015 publication, it is estimated that every year approximately 648,000 patients in the US got infected by bacteria during a hospital stay, and around 75,000 died. The increasing incidences of bacterial infection may support this market positively.

Europe is the second largest ultrasound probe disinfection market during the forecast period due to increasing prevalence of human papillomavirus (HPV). The human papillomavirus is a skin to skin transmitted disease. According to the Oxford Vaccine group fact sheet, HPV infection causes cervical cancers. It was also reported that 99% of cervical cancers are caused by the Human Papillomavirus (HPV) infection. Furthermore, it was also maintained that 3,126 new cases of cervical cancer were reported in the UK in 2015. The increasing prevalence of HPV infection supports the market growth in this region.

Asia-Pacific was estimated to be the fastest growing region for the global ultrasound probe disinfection market in 2017. The market is expected to witness high growth owing to the rising prevalence of bacterial infections. The Middle East and Africa holds the low share for this market. However, the rising healthcare awareness at the hospital and in the community are expected to influence the market positively.

Key Players

Some of the key players in the global ultrasound probe disinfection market are STERIS (UK), Nanosonics (Australia), Tristel (UK), Ecolab (US), Schülke & Mayr (Germany), Advanced Sterilization Products (US), CIVCO Medical Solutions (US), Germitec (France), Parker Laboratories (US), CS Medical (US), Virox Technologies (Canada), and Metrex Research (US).

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/ultrasound-probe-disinfection-market-6642

Global Liquid Handling System Market Trend, Industry Overview, Competitive Analysis And Foreseen By 2023

Market Scenario

Global liquid handling system market is expected to grow significantly over the forecast period. It is anticipated that the market held a market value of USD 2.95 billion in 2017 and is projected to grow at a CAGR of 8.7% over the forecast period. The liquid handling system is a laboratory instrument system consisting of tools and equipment designed to execute mixing, sampling, and combining of liquid samples. The factors such as an increase in investments in drug development, growing demand for high-output screening, growing expenditure on research & development (R&D), and rising adoption of automation in clinical settings are expected to drive the market growth over the forecast period. According to the World Bank, in the US, the research and development expenditure (as % of Gross Domestic Product) was 2.79% in 2015.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6588

Despite the drivers, the high cost associated with the liquid handling systems and complex operability of the latest liquid handling systems is anticipated to restrain the growth of the market over the assessment period.

Segmentation
The global liquid handling system market has been segmented into type, product, application, and end-user.
The market, on the basis of type, has been segmented into manual, automated, and electronic liquid handling system. The electronic liquid handling system segment is expected to hold major market share in 2017 owing to the high accuracy and reproducibility offered by the electronic liquid handling system.
The market on the basis of product has been segmented into pipettes, consumables, microplate reagent dispensers, liquid handling workstations, burettes, software, and others. The pipette segment has been segmented into manual pipettes, electronic pipettes, and semi-automated pipettes. The consumables segment has been segmented into disposable tips, tubes and plates, reagent containers, and others.
The global market, by application, has been segmented into drug discovery, genomics, clinical diagnostics, proteomics, and others. The drug discovery segment has been segmented into ADME screening, high-throughput screening (HTS), compound weighing and dissolution, and others. The genomics segment has been segmented into genotyping, next-generation sequencing (NGS), polymerase chain reaction (PCR), DNA/RNA purification, and others. The clinical diagnostics segment has been segmented into sample preparation, ELISA, and others.
The market, by end-user, has been segmented into pharmaceutical & biotechnology companies, contract research organizations (CRO), and others.
The global liquid handling system market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The liquid handling system market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European liquid handling system market has been segmented into Western Europe and Eastern Europe. Western Europe has further been segmented as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The liquid handling system market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The liquid handling system market in the Middle East & Africa has been segmented into the Middle East and Africa.
Key Players
Agilent Technologies, Danaher Corporation, Thermo Fisher Scientific, Inc., Eppendorf AG, Tecan Group Ltd., Bio-Rad Laboratories, Corning Incorporated, Sartorius AG, Hamilton Company, Mettler-Toledo International Inc., and Perkinelmer, Inc. are some of the key players in the global liquid handling system market.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/liquid-handling-system-market-6588

Global Electrical Hospital Beds Market Solid Segment Analyzed By Latest Trends, Growth Rate And 2023 Insight

Overview:

The global electrical hospital beds market is expected to touch a valuation of USD 2,595.4 million by 2023, according to Market Research Future (MRFR). The increasing medical tourism in developing economies has become a lucrative opportunity for major hospital chains. Electrical hospital beds are a necessity in hospitals which can assist patients with serious ailments in getting out of bed as well as provide a comfortable experience.

Rise of chronic diseases, the expanding geriatric populace, increasing rates of obesity, and inflated healthcare expenditure of nations are factors which can positively impact the market growth. Improved designs by bed manufacturers which focus on comfort is likely to provide the electrical hospital beds market demand the thrust in the right direction. The high costs of these beds can act as a growth deterrent. But demand for smart hospital beds coupled with technological advances in the healthcare sector can facilitate global market growth.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6552

Segmentation:

The electrical hospital beds market can be segmented by type, treatment, application, and end-user.

By type, the market is segmented into semi-automatic and fully automatic. The fully automatic segment accounted for 55% share in 2017, while the semi-automatic segment accounted for 45% share in the same year. The fully automatic segment is projected to experience a 8.83% CAGR over the forecast period owing to its extensive features such as controlling the lower part of the bed.

By treatment, the market covers acute care, critical care, and long term care. The critical care segment is expected to enjoy an 8.03% CAGR over the forecast period. It had dominated the market in 2017 owing to the sharp rise of electrical beds in intensive care units.

Major market applications include general purpose, intensive care, delivery/birthing, bariatric, pediatric, pressure relief, and psychiatric care. The general purpose segment accounted for the highest market share in 2017, followed by the intensive care segment. It is predicted to reign in the electrical hospital beds market over the assessment period owing to its high usage in sports academies, old age homes, rehabilitation centers, and others.

End-users in the electrical hospital beds market include hospitals and clinics, reproductive care centers, home care, and dentistry. Among these, the hospitals and clinics segment accounted for 40% market share in 2017, followed by reproductive care, dentistry, and home care segments. It is predicted to experience a 7.25% CAGR over the forecast period.

Regional Analysis:

The electrical hospital beds market covers the latest trends and opportunities across Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).

The European region accounted for 34% market share in 2017, followed by Americas (31%), APAC (25%), and MEA (10%). It can enjoy a 7.46% CAGR over the forecast period owing to its sophisticated healthcare infrastructure and emphasis on patient health by prominent nations. Countries such as the U.K., France, and Germany can drive the regional market size to USD 906.4 million by 2023.

The Americas region can enjoy a substantial growth rate over the forecast period owing to strong economies of Canada and the U.S. Introduction of beds with ergonomic designs and cost-effective prices are likely to induce massive demand from patients emphasizing on home care.

The APAC electrical hospital beds market is projected to grow at a rapid clip thanks to improvements in the healthcare sector, increasing medical tourism, and a dearth of opportunities owing to the large patient pool. It is expected to enjoy a 8.47% CAGR over the forecast period.

Competitive Dashboard:

Prominent players operating in the electrical hospital beds market include Paramount Bed Holding Co., Ltd. (Japan), Famed Zywiec Sp.zo.o. (Poland), Amico Group of Companies (Canada), Invacare Corporation (U.S.), Medline Industries, Inc. (U.S.), Merivaara Corporation (Finland), Span America Medical System, Inc. (U.S.), Linet spol.s.r.o. (Czech Republic), Gendron, Inc. (U.S.), ArjoHuntleigh (Sweden), Malvestio Spa (Italy), Stryker Corporation (U.S.), Midmark Corporation (U.S.), Hill Room Holding (U.S.), and Getinge AB (Sweden).

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/electrical-hospital-beds-market-6552

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Paraneoplastic Syndrome Market Key Manufactures Shares, Analysis And Forecasts Till 2023

Market Highlights

A paraneoplastic syndrome is a set of signs and symptoms which develops from tumor or cancer. This syndrome can be mostly seen in middle-aged to older patients and are often seen in patients suffering from breast cancer, lung cancer, and lymphatic or ovarian cancer. Sometimes, patients with paraneoplastic syndrome do not show symptoms even after the diagnosis, but there exists a rare condition where patients show symptoms of the paraneoplastic syndrome even before diagnostic tests are carried out.

Factors such as the increasing prevalence of cancer, awareness regarding breast cancer, and an unhealthy lifestyle drive the growth of the global paraneoplastic syndrome market. Moreover, rising investments in research and development activities and increasing healthcare expenditure are few more factors driving the global paraneoplastic syndrome market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6524

On the other hand lack of awareness regarding cancer and stringent regulations may hamper the growth of the market.

The global paraneoplastic syndrome market is dominated by many market players. The key players in the market are engaged in new launches and strategic collaborations to hold their market position.

Regional Analysis

The Americas is anticipated to dominate the global paraneoplastic syndrome market. The market growth in this region is attributed to the increasing geriatric population with paraneoplastic syndrome disorder, investment in research and development, and technological advancements.

Europe is expected to be the second largest market in the globe owing to the increasing number of geriatric population, increasing awareness regarding breast cancer, the presence of disposable income, and increasing consumption of tobacco in this region.

Asia-Pacific is anticipated to be the fastest growing market owing to the growing prevalence of paraneoplastic syndrome and cancer-related problems in developing countries, increasing disposable income, and growing healthcare expenditure.

The Middle East and Africa is expected to account for the lowest market share in the global paraneoplastic syndrome market due to low development, lack of technical knowledge, and poor medical facilities in developing economies in this region.

Segmentation

The global paraneoplastic syndrome market has been segmented into types, diagnosis, treatment, and end users. Based on types, the market is segmented into the cutaneous paraneoplastic syndrome, gastro-intestinal paraneoplastic syndrome, endocrine paraneoplastic syndrome, hematologic paraneoplastic syndrome, renal paraneoplastic syndrome, rheumatologic paraneoplastic syndromes, and neurologic paraneoplastic syndrome.

The market, by treatment, has been segmented into medication and therapies. Medication is further sub-segmented into corticosteroids, immunosuppressants, anti-seizure medications, plasmapheresis, and intravenous immunoglobulin (IVIg). On the basis of therapies, the market is further sub-segmented into physical therapy and speech therapy.

The market on the basis of diagnosis has been segmented into blood test, spinal tap (lumbar puncture), and imaging tests. Imaging tests are further sub-segmented into computerized tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), and PET plus CT.

Based on end-user, the market is segmented into hospitals and clinics, diagnostic centers, and ambulatory care centers.

Key Players

Some of the key players in the global paraneoplastic syndrome market are Healthineers, Koninklijke Philips N.V., General Electric Company, Esaote SpA, NeuroLogica Corporation, Masimo Corporation, York Instruments Ltd., Neusoft Medical Systems, and Canon Medical Systems Corporation.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/paraneoplastic-syndrome-market-6524

About Market Research Future:

Healthcare Cloud Computing Market Professional Overview 2020-2023 With Major Vendors Size, Shares And Worldwide Demand

Healthcare Cloud Computing Market Overview:

The global healthcare sector is pushing the healthcare cloud computing market ahead as the demand for smooth workflow is increasing. Market Research Future (MRFR) declared in their report that the global market for healthcare cloud computing would register strong growth. Major factors to drive the market ahead would be inclusion of internet of things (IoT), high influx of money, better technological influx, and others. Various companies are making several changes in their policies to assist the healthcare sector in finding better avenues for top-class setup.

However, the market may find the growth a bit limiting in terms of initial cost of installation. At the same time, the system needs trained officials to operate lack of which can deter the growth.

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/6519

Healthcare Cloud Computing Market Segmentation:

The global report on the healthcare cloud computing market has been segmented by applications, deployment, service, and end-user. This segment-wise study provides a proper look into various details that could facilitate the growth of the market.

By applications, the report on the healthcare cloud computing market includes namely Non -Clinical Information System (NCIS), and Clinical Information System (CIS). The CIS segment encompasses pharmacy information system (PIS), computerized physician order entry system (CPOE), electronic health records (EHR), and others. The EHR segment is witnessing high growth.

By deployment, the report with details of the healthcare cloud computing market can be segmented public cloud, private cloud, and hybrid cloud. The hybrid cloud segment is gaining momentum.

By services, the global report on the Healthcare cloud computing market includes several forms like Infrastructure-As-A-Service, Software-As-A-Service, and Platform-As-A-Service. The SaaS model is providing substantial backing to the market.

By end users, the report on the healthcare cloud computing marketcontains Healthcare providers and healthcare players.

Healthcare Cloud Computing Market Regional Analysis:

The global market for healthcare cloud computing is going to witness substantial changes in the North American market. This is primarily as a result of the back up the market is experiencing from countries like the US and Canada. These countries have top-class IT and healthcare infrastructure, which makes it easier for the associated parties to include major technologies.

In Europe, the growth curve would follow a similar trajectory. This would be possible due to the healthcare investment in countries like Germany, France, Italy, the UK, and others. Expansive measures would help the healthcare cloud computing market to proliferate. In Asia Pacific, major market players are trying to create an impact to tap the huge resource. Emerging economies are also inspiring this change as they are revamping the setup to facilitate easy entry of top-class technologies.

Healthcare Cloud Computing Market Competitive Landscape:

The report on the healthcare cloud computing market would cover several companies like CareCloud Corporation, Agfa-Gevaert N.V., Carestream Corporation, Merge Healthcare Inc., International Business Machines (IBM) Corporation, Microsoft Corporation, Oracle Corporation, Cerner Corporation, Sectra AB, Nuance Communications, ClearData Networks Inc., athenahealth Inc., GE Healthcare, Siemens Healthineers, NextGen Healthcare, and Dell Inc. to ensure better understanding of how the market is expanding. The study has all the tactical moves of these companies covered.

Healthcare Cloud Computing Industry News:

In March 2020, Qumulo announced that they would provide their cloud service for the healthcare system for free to healthcare organizations and personnels to fight against the ongoing troubles created by COVID-19 virus.

Microsoft is planning to boost the output of its research wing to support the growth of the healthcare cloud computing segment. The company has realized the potential of this segment and is ready to explore it to a great extent to cement their market position.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/healthcare-cloud-computing-market-6519

About Market Research Future:

Open System Isolator Market Shares Analysis, Key Development Strategies And Forecasts Till 2023

Market Highlights

The pharmaceutical industry is known as highly regulated industry and it is necessary to maintain the aseptic environment during the manufacturing process to meet the standards. Pharmaceutical isolators provide aseptic conditions and prevent the operator from being exposed to hazardous elements. The growing adoption of new technology in the manufacturing process, increasing use of open system isolators in research and development activities, and stringent regulatory policies are the major factors driving the growth of the global open system isolator market. Additionally, increasing R&D spending and aggressive strategies adopted by the top players, such as new product launches, are contributing to the growth of the market. For instance, in March 2017, COMECER S.p.A. cf. p.iva . has introduced The New Thecla Shielded Isolator in the market, this new isolator was introduced in the global market which will be available for use in academic as well as commercial manufacturing.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6515

The high risk of contamination, costs associated to open system isolators and a shortage of technicians may hamper the growth of the market during the assessment period.

Regional Analysis

The market in the Americas is expected to dominate the global open system isolator market during the forecast period owing to the increasing pharmaceutical manufacturing, strict government and regulatory authorities and well-established healthcare sector in the region. The European market is expected to be the second-largest due to the surge in research and development activities in the region along with growing concern about safety and efficacy of pharmaceutical products. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the forecast period owing to increasing production of generic pharmaceuticals in the region along with an increase in a number of manufacturing plants due to favorable conditions. The market in the Middle East & Africa is likely to account for the smallest share of the global open system isolator market.

Segmentation

The global open system isolator market has been segmented on the basis of pressure, application, and end-user.

The market by pressure has been divided into positive pressure isolators and negative pressure isolators.

On the basis of application, the market has been divided into, fluid dispensing isolators, aseptic filling isolators, product contaminants isolators, sampling/weighing/distribution isolators, and others

The end-user segment has been classified into pharmaceutical and biotechnological industries, academic & research institutes, hospitals and diagnostic laboratories and others.

Key Players

Some of the key players in the global open system isolator market are Schematic Engineering Industries, Gelman Singapore Pte Ltd, COMECER S.p.A. cf. p.iva, Getinge AB, IsoTech Design, LAF Technologies Pty Ltd, Fedegari Autoclavi S.p.A, Hosokawa Micron Ltd, Robert Bosch GmbH, Azbil Telstar, MBRAUN, NuAire Inc, VanRx Pharmasystems Inc, Skan AG, Chamunda Pharma Machinery Pvt. Ltd., and GERMFREE

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/open-system-isolator-market-6515